K091579 is an FDA 510(k) clearance for the FORESEE HOME. Classified as Perimeter, Automatic, Ac-powered (product code HPT), Class I - General Controls.
Submitted by Notal Vision , Ltd. (Laguna Beach, US). The FDA issued a Cleared decision on December 23, 2009 after a review of 204 days - an extended review cycle.
This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.1605 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.
NCT00776451
Completed
Observational
Industry-sponsored
Usability of the PreView PHP for Home Use in Intermediate AMD Patients
Usability of the PreView PHP for Home Use in Intermediate Age Related Macular Degeneration Patients
| Condition studied |
Age Related Macular Degeneration |
| Eligibility |
All sexes
· 65 Years+
|
| Principal investigator |
Neil Bressler, Prof. |
| Sponsor |
Notal Vision Ltd.
(industry)
|
Started 2008-11-01
→
Primary completion 2009-02-01
→
Completed 2009-03-01
Primary outcome
The proportion of subjects who successfully completed the test by themselves, in a home simulated environment
Study completed - no results published.
This trial concluded in 2009 but has not posted
results to ClinicalTrials.gov. Completed studies without public results are common
in industry-sponsored device trials; the data may be referenced in the
510(k) Summary PDF or remain unpublished.
View full study on ClinicalTrials.gov